SS
PRME icon

SBI Securities’s Prime Medicine PRME Stock Holding History

SBI Securities’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36K Buy
391
+88
+29% +$335 ﹤0.01% 2543
2025
Q4 		$1.05K Sell
303
-697
-70% -$3.1K ﹤0.01% 2627
2025
Q3 		$5.54K Buy
1,000
+273
+38% +$1.11K ﹤0.01% 1996
2025
Q2 		$1.8K Buy
727
+153
+27% +$236 ﹤0.01% 2431
2025
Q1 		$1.14K Sell
574
-631
-52% -$1.61K ﹤0.01% 2525
2024
Q4 		$3.52K Buy
+1,205
New +$4.23K ﹤0.01% 2061

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

SBI Securities's PRME Position: Q1 2026 in Review

SBI Securities increased its Prime Medicine (PRME) stake by 29% in Q1 2026, buying an estimated $335 and bringing the position to 391 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #2543.

SBI Securities first reported a position in PRME in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.54K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • SBI Securities held 391 shares of Prime Medicine worth $1.36K as of Q1 2026.
  • SBI Securities bought 88 Prime Medicine shares in Q1 2026, an estimated $335.
  • Prime Medicine made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2543 holding.
  • SBI Securities first reported a position in Prime Medicine in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Prime Medicine position peaked at $5.54K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.